Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTH-IA in Jansen's Metaphyseal Chondrodysplasia
NCT07541209Phase 2Recruiting
- Sponsor
- National Institute of Dental and Craniofacial Research
- Start
- May 2026
- Primary completion
- Jun 2029
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of PTH-IA in Jansen metaphyseal chondrodysplasia (JMC), sponsored by National Institute of Dental and Craniofacial Research. Started May 2026; status: recruiting.
02
Drugs
PTH-IA
03
Conditions
Jansen metaphyseal chondrodysplasia (JMC)
Beyond the preview
Go deeper on NCT07541209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07541209.